oral glp 1 for weight loss With FDA approval of Wegovy pill, new era of GLP-1 drugs begins burn more Novel oral GLP-1 receptor agonist

February 1, 2025

Nausea: Often temporary and improves over time Diarrhea: Usually mild to moderate Vomiting: More common during dose titration Constipation: May occur in some people Stomach discomfort: Typically decreases with continued use Serious side effects to watch for Though less common, some side effects require immediate medical attention

We make healthy habits as easy as possible one small, repeatable step at a time

View the LIV Body GLP-1 program - see current offer and eligibility details (official LIV Body page) How to Read LIV Body's Marketing Language LIV Body runs active advertising

GLP-1 RAs impact cardiac myocytes in conditions such as myocardial infarction, heart failure preserved ejection fraction (HFpEF), and cardiomyopathy

Youle RJ, van der Bliek AM